Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma

The recent development and clinical implementation of novel immunotherapies for the treatment of Hodgkin and non-Hodgkin lymphoma have improved patient outcomes across subgroups. The rapid introduction of immunotherapeutic agents into the clinic, however, has presented significant questions regardin...

Descripción completa

Detalles Bibliográficos
Autores principales: Neelapu, Sattva S, Adkins, Sherry, Ansell, Stephen M, Brody, Joshua, Cairo, Mitchell S, Friedberg, Jonathan W, Kline, Justin P, Levy, Ronald, Porter, David L, van Besien, Koen, Werner, Michael, Bishop, Michael R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Position Article and Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768967/
https://www.ncbi.nlm.nih.gov/pubmed/33361336
http://dx.doi.org/10.1136/jitc-2020-001235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768967/
https://www.ncbi.nlm.nih.gov/pubmed/33361336
http://dx.doi.org/10.1136/jitc-2020-001235

Ejemplares similares